
Ron Finklestien
PotlatchDeltic Q4 Revenue and 2024 Outlook
PotlatchDeltic’s Growth and Challenges: Q4 Revenue Surges, 2024 Outlook Delivered
Taiyou Nomachi/DigitalVision via Getty Images PotlatchDeltic, listed as NASDAQ:PCH, saw a reduction in Q4 EBITDDA for its Timberlands and Woods products business, but this ...
Is Arista Networks (ANET) a Worthy Investment?
Wall Street Analysts Look Bullish on Arista Networks (ANET): Should You Buy?
Stock market investors often rely on the opinions of Wall Street analysts to make investment decisions. The current brokerage recommendations for Arista Networks (ANET) ...
Franklin Resources Inc. Shines with Strong Q1 Earnings and Revenue, AUM on the Rise
Franklin Resources Inc. impressed investors with its first-quarter fiscal 2024 earnings, reporting a surge from 57 to 65 cents per share, surpassing the Zacks ...
Financial News Roundup
Investor Alert: TD Cowen Downgrades Piedmont Lithium While Biden Puts Pressure on US Steel Deal
Today’s Top Stories: TD Cowen Downgrades Piedmont Lithium In a surprising turn of events, TD Cowen announced the downgrade of Piedmont Lithium Inc. (PLL) ...
REV Group Inc: Significant Strategic Moves Drive Share Surge
REV Group Inc: Significant Strategic Moves Drive Share Surge
Strategic Business Actions REV Group IncREVG shares are trading higher after the company announced a significant dividend and crucial strategic actions. Effective January 26, ...
Albertsons Faces Hurdles as Amazon’s Purchase of iRobot is Terminated
Albertsons Faces Hurdles as Amazon’s Purchase of iRobot is Terminated
RiverNorthPhotography/iStock Unreleased via Getty Images Albertsons, trading under the ticker symbol NYSE:ACI, saw a 1.1% decrease as a result of Amazon and iRobot mutually ...
Momentum Unleashed
Momentum Unleashed
Want to start the week ahead of the pack? Check out Momentum Mondays, where I cover the leading breakout stocks in the market, summarize ...
The Brewing Storm: Amazon (AMZN) to Unveil Q4 Earnings Amid High Expectations
Amazon (AMZN) is slated to report its financial results for the fourth quarter of 2023 on February 1. The company anticipates net sales ranging ...
Panbela Therapeutics Announces Pricing of $9 Million Public Offering Resulting in 65% Decline in Shares
Shares of Panbela Therapeutics, Inc.PBLA plummeted by 65.5% to $1.47 after announcing a roughly $9 million public offering. Several other stocks had significant value ...















